U.S. Markets closed

Progenics reports 2Q loss

NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Wednesday reported a loss of $16.6 million in its second quarter.

The New York-based company said it had a loss of 24 cents per share.

The biopharmaceutical company posted revenue of $2.8 million in the period.

Progenics shares have decreased 30 percent since the beginning of the year. The stock has dropped nearly 5 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX


Keywords: Progenics, Earnings Report